This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a trifluoromethoxy group and a dihydrobenzofuran moiety, makes it a valuable intermediate in the creation of compounds targeting central nervous system disorders. It is often explored for its potential in developing drugs that modulate neurotransmitter activity, such as serotonin or dopamine receptors, which are crucial in treating conditions like depression, anxiety, and Parkinson's disease. Additionally, its unique chemical properties are leveraged in the design of molecules with enhanced bioavailability and metabolic stability, making it a key component in the optimization of drug candidates.